Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products

Tissue Regeneration Systems Inc. (TRS), a developer of bio-active implants, entered into an agreement with DePuy Synthes Products, LLC, a medical device company, and Johnson & Johnson Innovation Center, to develop resorbable implants for large bone segmental defect treatment in trauma and orthopaedic oncology.

Under the agreement, the partners will develop implants by using DePuy Synthes’ expertise and market leadership with TRS’s 3-D printing technologies and development expertise. The agreement also includes potential future development opportunities in a range of additional applications within DePuy Synthes’ areas of strategic interest.


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button